written on 03.09.2019

Expand awareness of dementia and explore the latest scientific breakthroughs at the Financial Times Dementia Summit 18th September 2019 in London


Register Now>>


As the global prevalence of dementia expands and new breakthroughs are made, the market for dementia-related products and services is set to enter a new era. The FT Dementia Summit will explore the latest advances in diagnosis and treatment while addressing the challenges facing those responsible for bringing new ideas to life. What are the treatments of tomorrow? How is the role of carers evolving? What can policymakers do to support progress?


Attendees will hear from key opinion leaders at the cutting edge of dementia research, including leaders from the NHS, Alzheimer’s Society, World Dementia Council, the Care Quality Commission and more. The one-day summit offers the opportunity to explore new ideas to achieve a more dementia-friendly society, analyse the market for dementia-related products and services, and network with the full spectrum of stakeholders across the dementia landscape.

Some of the 23 speakers include:

  • Alistair Burns, National Clinical Director for Dementia, NHS England
  • Fiona Carragher, Chief Policy and Research Officer, Alzheimer’s Society
  • Adrian Ivinson, Co-Director and COO, UK Dementia Research Institute
  • Lenny Shallcross, Executive Director, World Dementia Council
  • Catherine Mummery, Clinical Director of Neurology, National Hospital for Neurology and Neurosurgery


Register Now>>



About the Financial Times

The Financial Times is one of the world’s leading business news organisations, recognised internationally for its authority, integrity and accuracy. The FT has a record paying readership of one million, three-quarters of which are digital subscriptions. It is part of Nikkei Inc., which provides a broad range of information, news and services for the global business community.